Oceanpine Capital

Oceanpine Capital, founded in 2016, is a growth equity investment firm with offices in Beijing, Hong Kong, and Silicon Valley. The firm focuses on investing in disruptive technologies within sectors such as semiconductors, AI, 5G, IoT, big data, enterprise software, and biotech. Oceanpine aims to build long-term partnerships with visionary entrepreneurs to develop world-class companies. Oceanpine Capital has raised significant funds, including a $400 million debut fund and another $400 million for Fund II. The firm has invested over $1 billion across more than 40 companies in China and the US. Notable portfolio companies include Enflame Technology, Ansun Biopharma, Horizon Robotics, Black Sesame, and TigerGraph. Oceanpine's investment strategy emphasizes DeepTech and innovative growth companies, aligning with their commitment to fostering advancements in technology and healthcare sectors​.